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Abstract
Many basic multicellular organisms possess some form of immune response to protect themselves against the invasion of foreign
objects. It was not until British scientist, Peter Medawar proposed a fundamental question that changed the way researchers
studied the maternofetal relationship. A fetus, being genetically different from its mother should be rejected by the maternal
immune system, however, it is not. Researchers have since discovered and developed several mechanisms that aim to explain how
the maternal immune system prevents fetal rejection.The formation of a mechanical barrier, general and local suppression of the
maternal immune system, and a shift in cytokine concentration during pregnancy have been suggested as reasons Forthcoming
discoveries in the field of reproductive immunology may further one’s understanding of immune regulation during pregnancy, in
addition to other applications, such as, the immune responses regarding organ transplants. Although the proposed mechanisms
mentioned above helped improve the understanding of how fetal rejection is avoided, many scientists concur that additional
research is required to adequately explain the prevention of fetal rejection.
Abbreviations:
Ab- Antibody
Ag- Antigen
APC- Antigen presenting cell
MHC- Major Histocompatibility Complex
IDO- Indoleamine 2,3-dioxy-genase
Ig- Immunoglobulin
IL-2- Interleukin 2
IFN-γ- Interferon Gamma
TNF-β- Tumor Necrosis Factor Beta

Introduction and Background
The National Vital Statistics Reports presented data from a
study conducted regarding the total number of births registered in the United States, in 2015. The results showed that
there were 3,978,497 births recorded, only 1% less than the
total number of births registered in 2014 (Martin, et al. 2017).
Many women, worldwide, have successfully given birth to babies,
which interests researchers in the field of immunology. During a
lecture in England, in 1953, a British immunologist named Peter
Medawar asked, “how does the pregnant mother contrive to
nourish within itself, for many weeks or months, a fetus that is
an antigenically foreign body (Betz, 2010)?” Since then, researchers have been asking the same question (Anonymous, 1999)?

Methods
The research discussed in this paper was compiled from various
published articles, taken from Touro’s database, including Proquest
Science, EBSCO, and PubMed to research why a mother does not
reject a genetically different fetus growing inside of her.

Discussion
A.The immune system targets foreign objects
The human body’s immune system is a complex network of
biological structures intricately designed to protect the body
against foreign objects. Foreign objects may be anything the
body does not recognize as self, which may include, bacteria,
viruses, parasites, and tumors. When a foreign object enters the
body, there is a cascade of events carried out by the body’s

immune system. First, the body must identify the foreign object
as “non-self”, destroy the pathogen, and lastly, create memory
cells to ensure that the foreign object does not attack again
(Gilley, et all. 2009).

1.Recognizing “non- self ” Objects
One of the main roles of the immune system is to recognize a
pathogen and induce a response to eradicate it. Immune system
cells such as white blood cells or leukocytes aid in carrying out
the tasks. In order to initiate any immune response, an antigen
(Ag) must be recognized by special receptors. T-Lymphocytes,
killer T cells and helper T cells, play a crucial role in the recognition of Ag. T-cells recognize foreign Ag by the presentation of
peptides by the major histocompatibility complex (MHC). The
two classes of MHC are MHC I and MHC II. Major histocompatibility complex class I generally presents an intracellular viral Ag
to cells that contain CD8+ proteins. These Ag will be destroyed
by Cytotoxic T-Lymphocytes, while MHC Class II generally
presents extracellular bacterial Ag to cells that contain CD4+
proteins.These Ag are recognized by Helper T-Lymphocytes and
will be destroyed with the help of Ab. (Joyce, 2001). CD8+ and
CD4+ are cell surface molecules that bind to their respective
MHC on an antigen-presenting cell (APC). One of the most
common cells that act as an APC are macrophages. (Miceli,
Parnes, 1991).

2.Destroying a Pathogen
After the body recognized a pathogen as “non-self,” the immune
system will try to rid the body of the foreign object. There are
two main types of pathogens that will elicit two different responses. The first type is when bacteria enter the human body;
helper T cells will release certain cytokines and chemokines.
These are certain chemicals that act as chemoattractants for
other leukocytes to aid in an inflammatory response. Secondly,
will produce Plasma cells, a derivative of lymphocytes, make antibodies (Ab) that will help destroy the pathogen. Antibodies
are a Y shape structure, consisting of glycoproteins called immunoglobulins (Ig). There are 5 main isotypes of Ig with different
roles, which include: IgG, IgE, IgM, IgA, IgD. Each Ab will bind to a
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specific antigen, comparable to the interaction with a lock and a
key (Author Unknown, 2016).
In order to help T cells produce Ab, B- lymphocytes will produce specific Ab to help destroy pathogens.Antibodies produced
by B cells will circulate the body via the bloodstream and can
bind to foreign objects. After a B-cell recognizes a pathogen, the
cell matures into a plasma cell, which produces large quantities
of Ab. Antibodies have 3 main functions in the immune system.
The first role is neutralization, which is when an Ab binds to the
surface of the pathogen, thus denying any entry into the normal
body cells. The second role is to activate other defense cells
that are in the body that can elicit an inflammatory response, for
example, phagocytes. The third role is to activate a complement
system, which attracts defense cells to the infection site and
destroys the pathogen (Author Unknown, 2016).
The second type of pathogen that will cause an immune response is infection with a virus. In this case, activated Cytotoxic
T- cells are able to directly destroy the pathogen when it displays pathogen peptides on the MHC Class 1. Cytotoxic- T cells,
also called Killer T cells release cytotoxins, such as perforin,
which creates a hole in the wall of the infected cell. This in turn
kills the cell along with the pathogen due to the loss of fluid
(Author Unknown, 2016)

B. Fetal Cells and a Mother’s Immune System
In order to better explain the interaction between fetal cells
and the mother’s immune system, one must understand what
happens after a sperm fertilizes an egg. Once an egg is fertilized,
it rapidly divides to form the blastocyst, a hollow ball of cells
comprised of two portions. One is the inner cell mass that will
become the embryo, which will develop into a fetus about eight
weeks after conception. The second is the outer layer of the
blastocyst, which will become the trophoblast. The trophoblast
will ultimately occupy the lining of the uterus, thus facilitating
embryonic implantation (Urman, Balaban 2001).

C. Immune System During Pregnancy
Based on the roles of the human’s immune system, one could
assume that a mother’s immune system would try to eliminate
a fetus. When a mother conceives a child, genetic material from
both the mother and the father are incorporated into the fetus,
however the mother’s mother’s side of the placenta is genetically different from the fetus. Therefore, the fetus inside the womb
would be considered “non-self” (Lightner, et al, 2008). Peter B.
Medawar suggested the “immunological paradox of pregnancy”
(Mor, 2007). He proposed that since the fetus is considered
“semiforeign,” there must be a conflict between the fetus and
the mother’s immune system. For over 60 years since Medawar
posed this phenomenon, there have been many attempts to
explain why a mother’s immune system does not reject a genetically different fetus.
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Accepted Hypotheses
a. Mechanical Barrier
The first hypothesis explains that the fetal tissue is unrecognizable as “nonself” by the mother’s immune cells due to a mechanical barrier (Mor, 2007). The uterus of a pregnant mother has a
mechanical barrier, consisting of synctiotrophoblasts that envelop
the fetus. This trophoblast-immune interaction includes three
stages (Fig. 1). During the first stage of attraction, the trophoblast
cells secrete chemoattractants that will signal immune cells to
migrate to the implantation site. The implantation site refers to
the area of the uterus in which the trophoblasts invade. After
attraction, the trophoblasts produce cytokines that regulate the
differentiation of immune cells. This stage is called recruitment
and/or education. Upon completion of these two steps, the response can take place. In this stage, the immune cells from stage
two respond to different signals (Swain, 2013). After completion
of all three stages, the mechanical barrier is formed. This in turn
prevents the movement of activated T cells from the periphery
to the implantation site and enables antigens that are inside the
barrier to be undetected by the mother’s immune system.

b. Suppressed Immune System During Pregnancy
Research done by David Munn and his colleagues at the Medical
College of Georgia in Augusta suggests a different hypothesis.
They discovered that macrophages, an important immune cell
involved in antigen presentation, can disable killer T-cells. This
in turn will prevent the T cells from attacking any object that is
recognized as non-self (Anonymous, 1999). In order for this to
occur, the synctiotrophoblasts in the placenta produces an enzyme known as indoleamine 2,3-dioxy-genase (IDO). The function of IDO is to destroy tryptophan, an amino acid required
by T cells to destroy a foreign object. In 1990, Andrew Mellor, a
colleague of Munn, concluded that IDO inhibits a mother’s T cell
response towards a genetically different fetus. On the contrary,
if a mother fails to produce IDO, it would cause the mother to
miscarry (Gura, 1998).
Munn and his colleagues conducted experiments in to prove
their hypothesis. They used two groups of pregnant mice; one
group had been bred to genetically identical fathers of the same
strain while the second group was bred to fathers from a genetically different strain (Gura, 1998). The experimenters then
embedded time release-capsules consisting of either 1-methyl-tryptophan, which is an IDO inhibitor, or a control substance
underneath the skin of the pregnant mice. Results showed that
only the mice carrying genetically different fetuses that had
been given the inhibitor rejected their fetuses (Anonymous,
1999) (Gura 1998). Interestingly, the embryos developed normally until inflammatory cells migrated to the implantation site
and caused hemorrhaging around the embryo. Munn proposed
“the mother is rejecting the placenta and eventually the embryo chokes off and dies” (Gura, 1998). From the data collected,
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Munn and his colleagues concluded that after implantation, an
embryo starts making connections with the mother’s blood
supply. Sequentially, synctiotrophoblasts will start producing
IDO, destroying tryptophan and suppressing the maternal immune system (Gura, 1998). However, other researchers have
reservations about this hypothesis. In Pregnancy Reconceived,
Mor argues that if the maternal immune system is suppressed, it
would be nearly impossible for a mother and its fetus to survive.
Exposure to any pathogen would be fatal (Mor, 2007).

c. Local Active Suppression in Decidua
In addition to the general suppression of a mother’s immune
system, researchers have found that an important role in the
maternofetal interaction is the local active suppression by cells
in the decidua (Chaouat, 1990). The decidua is a mucous membrane lining of the uterus during pregnancy. This lining allows
for nutrition and gas exchange before the placenta is functional
(Mizugishi, et al. 2007). Cells located in the decidua may inhibit
the production of lymphocytes thus leading to the inhibition of
the production and expression of receptors for interleukin 2 (IL2). IL-2 is a cytokine signaling molecule produced by activated T
cells and is crucial for the rejection of foreign objects in the body.
This type of suppressor cell is trophoblast independent. However,
there is another type of cell that suppresses the role of IL-2 in
the maternal immune system and these suppressor cells in the
decidua are trophoblast dependent. ¬ Both types of suppressor
cells have an effect on the production or action of IL-2.
Therefore, local active suppression aids in the prevention of
foreign objects attacking the mother’s immune system and fetal
rejection (Chaouat, 1990.)

d. Cytokine-shift Hypothesis
This hypothesis suggests that during pregnancy, the balance
of cytokines within the mother’s body shifts. This cytokine
shift causes immunological changes in the maternal immune
response (Mor, 2007). Cytokines, which are important in cell
signaling, are released by Th1 and Th2 helper cells. However,
each subgroup facilitates a different immune response. Th1 cells
secrete IL-2, Interferon gamma (IFN-γ), and Tumor necrosis
factor, Beta (TNF-β) causing a cell mediated immune response,
while Th2 cells secrete IL-4, 5, 6, 10, and 13. These are mainly involved in antibody production (Rincón et.al, 1997). Additionally,
IL secreted by Th2 cells simulate a humoral immunity and aids
in the inhibition of the production of TNF-β and IFN-γ (Kidd
2003). The production of IFN-γ, TNF-β and IL-2 are believed to
be damaging to pregnancy. In an experiment studying pregnant
mice, these cytokines were injected into the mice and caused
fetal loss (Koch and Platt, 2003). Previous research suggests that
there is a shift towards a higher production of cytokines released by Th2 during pregnancy and a diminished production of
Th1 cytokines (Hoshimoto,et al. 2000).

When a foreign object enters the body of a women who is
not pregnant, Th1 cells will secrete pro inflammatory cytokines
that will signal for a cell mediated response to occur. However,
according to the cytokine-shift hypothesis, the balance of Th1
and Th2 will go towards the secretion of cytokines by Th2, resulting in a suppressed inflammatory response (Mor, 2007).)
Many studies have been conducted in an effort to better understand the shift of Th1 to Th2 cytokine secretion during
pregnancy. In an experiment conducted by Hoshimoto, et. al.
(2009), they gathered thirty female subjects. Group A consisted
of ten women who were non-pregnant women with regular
menstrual cycles and the other 20 healthy and pregnant women.
The pregnant women were separated into two groups, B and
C according to weeks of gestation. Group B consisted of 10
pregnant women who were in their first trimester and group C
consisted of 10 women in their third trimester.The experimenters took samples of peripheral venous blood and separated the
plasma at -80°C until ready for analysis. The results of the experiment showed the correlation between the plasma levels of
sCD26 and sCD30 and pregnancy. sCD26 and sCD30 are molecules on the surface of activated Th1 and Th2 cells, respectively.
Therefore, plasma levels of sCD26 and sCD30 correlate to Th1
and Th2 responses, respectively.
sCD26 concentrations among group A were significantly
higher than group B. Furthermore, the concentration of group
B was significantly higher than group C. This indicates that the
highest concentration of Th1 cells were among those who
were not pregnant, and the lowest concentration was among
the pregnant women in their third trimester. Concentrations of
sCD30 among groups A and B did not significantly vary, however, compared to the concentration level of group C, they were
significantly higher. The researchers concluded that there was a
significant decrease in sCD26 levels among pregnant mothers
possibly due to the shift from Th1 cytokine secretion. However,
sCD30 levels did not differ between non-pregnant women and
women in their first trimester, but decreased among women
in their third trimester. This decrease may be explained by
the increase in water retention as pregnancy progresses.
Furthermore, the researchers advise for additional investigation
in order to validate the cytokine-shift hypothesis.
Many researchers agree that cytokines play a crucial
role during pregnancy. As explained in the research done by
Hoshimoto et.al, Koch and Platt mutually agree that a Th2
response is necessary for the fetus to survive in the womb.
Results from an experiment with mice showed that there was
a 20-50% rate of fetal loss due to a lack of Th2 cytokine production. Furthermore, they applied this idea to humans and suggest that irregularities with Th2 cytokine response may lead to
miscarriages. The mechanism that causes the shift between Th1
and Th2 cytokine response in pregnancy is unknown. However,
Koch and Platt propose two plausible possibilities. Firstly, there
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is a prevention of Th1 cytokine secretion that allows the Th2
response to take over or secondly; there is a specific Th2 response, which inhibits the Th1 response (Koch, Platt, 2003).

Conclusion
This paper attempted to explain the reasons why a mother
does not reject her genetically different fetus. Although it was
not until the 1950’s when Professor Medawar first posed this
question, the wealth of knowledge on this topic is rapidly expanding. However, despite the few flaws with the hypotheses,
additional research is being studied to resolve the issue.
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